Ritodrine Hydrochloride

盐酸利托君

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRitodrine Hydrochloride
Drug Alias Nameritodrina盐酸利托菌ritodrine盐酸羟苄羟麻黄碱ritodrinum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors agonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsObstetric Labor, Premature
Global Approved IndicationsObstetric Labor, Premature
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1972/08/01
Country/TerritoryCanadaUnited StatesMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTaiwan Biotech Co Ltd
Inactive CompaniesAstrazeneca Plc
Active IndicationsObstetric Labor, Premature
Inactive IndicationsN/A

Other Information

ATC CodeG02CA01
Related LinksWikipediaDrugBankKEGG